and phentolamine) suppressed the slow response in a doserelated manner. The voltage-dependent block and usedependent block of the maximal rate of rise (V max) of action potentials by bunazosin (10- 5 to 10-4 M) and yohimbine (10-6 to 10-5 M) were studied. The analysis ofthe onset and recovery kinetics from the use-dependent block of drugs showed that both bunazosin and yohimbine act as slow kinetic drugs.
It is concluded that alpha-adrenoceptor antagonists seem to have an antiarrhythmic effect through the inhibition of fast sodium ion (Na +) and slow Ca H currents of Jhe cell membrane independently of blockade of myocardial alpha-adrenoceptors.
(J Am Call Cardiol1988; 12:1590-8) rine and the alpha2-adrenoceptor antagonists yohimbine (7) and piperoxan (6) potentiated its arrhythmogenic effect. These observations suggested that selective alphal-adrenoceptor stimulation and alpha2-adrenoceptor blockade increase the arrhythmogenic effects of ouabain, whereas selective alpha 2 -adrenoceptor stimulation and alpha\-adrenoceptor blockade inhibit it. Kimura et al. (8) also demonstrated the suppressive effect of prazosin on catecholamineinduced delayed afterdepolarizations and triggered activity in the presence of elevated calcium ion (Ca 2 +) levels. On the other hand, Mugelli et al. (9) reported that yohimbine but not prazosin antagonized norepinephrineinduced automaticity in hypoxic, glucose-free conditions. Moreover, Northover (10) attributed the antiarrhythmic effect of prazosin, yohimbine, tolazoline, dibenamine and phenoxybenzamine to the interaction with the cell membrane and not to inhibition of the alpha-adrenoceptors.
Despite the findings that prazosin (11, 12) , urapidil (13) , bunazosin (14) and yohimbine (12, 15, 16) reduce the maximal rate of rise (V max) of action potentials, somewhat higher concentrations of these drugs seem to be necessary to obtain the local anesthetic effect on the 'cell membrane compared with the dose required for their alpha-adrenoceptor antagonistic effect. Recent models of antiarrhythmic drug interactions with the myocardial sodium ion (Na+) channel (17, 18) have provided insight into subcellular mechanisms of drug action. These basic models have important clinical implications (19) .
The experiments in this study were carried out to determine whether alpha-adrenoceptor antagonists have an antiarrhythmic effect in guinea pig ventricular myocardium not mediated by the inhibition of alpha-adrenoceptors and, if they have, whether the mode of action can be explained by the model described.
Methods
Experimental preparation. Guinea pigs (200 to 300 g) were killed by a blow to the head. The papillary muscles (2.5 to 5 mm long and 0.8 to 1.3 mm in diameter) were rapidly excised from the right ventricle and mounted in a tissue bath perfused with oxygenated (95% oxygen [02], 5% carbon dioxide [C0 2 D Tyrode solution (pH 7.4 ± 0.05) at 36.0 ± 0.2°e. The flow rate was kept constant at a rate of 3 mllmin by using a microtube pump (Tokyo Rikakikai, model MP-3). The basal part of the muscle was pinned to a silicon rubber floor in the bath by means of bipolar stimulus electrodes connected to a stimulator (Nihon Kohden, model SEN-3201) through an isolator (Nihon Kohden, model SS-I021). Normal Tyrode solution had the following composition (in millimolars): sodium chloride, (NaCl) 132; potassium chloride, (KC)) 4; sodium hydrocarbonate, 12; sodium phosphate, 0.4; calcium chloride, (CaCI 2 ) 1.8; magnesium chloride, 1 and glucose, 10.
Membrane potentials were measured differentially using two microelectrodes filled with 3 M potassium chloride (KC!) (resistance 10 to 15 Mil) and led to an amplifier (Nihon Kohden, model MEZ-7101). Analog differentiation of the action potential was obtained with an electronic differentiator that was linear from 0 to 500 Vis (usual time constant 10 f-LS, 50 f-LS for slow action potentials). The action potential and the maximal rate of rise (V max) of the action potential were monitored on an oscilloscope (Nihon Kohden, model VC-IO), photographed by a camera (Nihon Kohden, model RLG-6201) and recorded simultaneously on a chart recorder (Nih on Kohden, model RJG-4122). The muscles were stimulated at a rate of 1 Hz (voltage 1.5 times threshold, duration 2 ms) during the period of equilibration after mounting and during analysis of the steady state effect of drugs. Stimulation rate and mode were varied for each protocol.
Slow action potential. The high K+ solution for induction of the slow response contained 27 instead of 4 mM KCI and 0.2 mM barium chloride (BaCI 2 ) in the normal Tyrode solution. The effect of drugs on the facilitatory effect of hypoxia in beta-adrenoceptor agonist-induced abnormal membrane responses was examined using our recently re-HAS EGA W A ET AL.
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ALPHA-ADRENERGIC BLOCKERS AS ANTIARRHYTHMICS ported method (20) . Hypoxia was induced by bubbling the solution with 95% nitrogen (N 2 ) and 5% CO 2 instead of the mixture of 95% O 2 and 5% CO 2 , Measurements of responsiveness were repeated during control (normoxia) and during hypoxia at around 1 h after its induction.
Transient depolarization. For induction of transient depolarization of the membrane potential the concentrations of KCI and CaCl 2 in the normal Tyrode solution were changed to 0.5 and 3.6 mM, respectively, and 1 to 5 X 10-7 M strophanthidin was added. In each solution after 10 min of equilibration, 1, 1.5, 2, 2.5 and 3 Hz stimulation for 10 s was applied.
Use-dependent block. The use-dependent block of V max was measured by a procedure similar to that already reported (21-29). The preparation was stimulated at rates of 0.2, I, 2 and 3 Hz for 30 to 60 s. These trains of stimuli were applied after every rest period of 90 s, which was sufficient for recovery from the use-dependent decrease in V max' The amount of use-dependent block was defined as percent decrease of V max from the value of first action potential to the steady state level, and that of tonic block as percent decrease of V max from the value of first action potential in control to that in the presence of a drug. For analysis of recovery kinetics from drug action, the preparation was stimulated with a rapid (2 Hz) train of impulses for 30 s after a 90 s rest period. Stimulation was then terminated and an extrastimulus was applied. The coupling intervals after termination of the trains were progressively increased from 0.5 to 1, 3 (31, 32) . Drugs. The following drugs were added to the solution just before each experiment: bunazosin hydrochloride (Eisai), yohimbine hydrochloride (Sigma), phentolamine mesylate (Ciba-Geigy), I-isoproterenol hydrochloride (Nikken) and strophanthidin (Sigma). To avoid interference of endogenous norepinephrine, the catecholamine content in the heart was lowered by pretreating the guinea pigs subcu- 
Results
Effect of alpha-adrenoceptor antagonists on the transient depolarization induced by low K+, high Ca2+ plus strophanthidin ( Fig. 1) . Figure 1 shows the membrane potentials of muscles during and after fast drives. Fast drives for 10 s were applied in normal Tyrode solution (controi), in the strophanthidin-containing test solution (0.5 roM K +,3.6 roM Ca2+, with 1 to 5 X 10-7 M strophanthidin) and in the presence of therapeutic concentrations of bunazosin or yohimbine in the test solution. In the test solution, the fast drives of the same frequencies were followed by a transient depolarization. In the presence of bunazosin or yohimbine, the amplitude of the transient depolarization was diminished. Similar results were obtained in four experiments for bunazosin and three for yohimbine. Effect of bunazosin on the beta-adrenoceptor-mediated abnormal automaticity during hypoxia (Fig. 2) . Responsiveness of muscle cells to beta-adrenoceptor agonist was evaluated from the concentrations of isoproterenol required for membrane depolarization alone and for automatic repetitive action potentials preceded by rapid depolarization (Fig. 2A) . In the hypoxic condition (Fig. 2B ) the responsiveness became higher than the control value, although in normal conditions repetitive trials did not alter the responsiveness of the preparation, as previously reported (33) . In the presence of 3 x 10-6 M bunazosin, hypoxia failed to increase the responsiveness of muscle cells.
Effects of alpha-adrenoceptor antagonists on the slow action potentials ( Fig. 3 and 4) . Because in catecholamineinduced membrane depolarization the beta-adrenoceptormediated increase in the slow inward current plays an important role (34) , the effect of the alpha-adrenoceptor antagonists bunazosin, yohimbine and phentolamine on the Ca2+ -mediated slow response was studied. At bunazosin concentrations> 10-5 M, slow action potentials showed a slow V max' reduced amplitude of overshoot and prolonged duration. Yohimbine reduced V max and overshoot in a dose-dependent manner even at low concentrations (Fig. 4) . Phentolamine, a nonselective alpha-adrenoceptor antagonist, suppressed the slow action potentials at relatively high concentrations (not shown). Effects of a1pha-adrenoceptor antagonists on the steady state normal action potentials stimulated at 1 Hz (Table 1) .
Bunazosin decreased V max and overshoot of action potentials in a dose-related manner. Simultaneous recording of muscle contractile force showed the reduction of force at increased bunazosin concentrations (not shown). (Fig. 5 and 6 ). After the tonic block of V max induced by bunazosin, further decline of V max to a new steady state (use-dependent block) during the train of stimuli depended on the stimulation frequency (Fig. 5A) . Development kinetics of use-dependent block at different stimulation rates can be defined in terms of either a time-dependent or an eventdependent process. In both cases, development kinetics represented a function of the interstimulus interval in that time constant and rate constant decreased with increasing stimulation rate. In the presence of to- observed although depolarization caused by rapid stimulation was similar to the control value.
Use-dependent block in V max induced by yohimbine was also investigated (Fig. 6A) , as well as the recovery kinetics of use-dependent block for yohimbine (Fig. 6B) . The mean value of recovery time constant in the presence of 10-5 M yohimbine for two experiments was 20.8 s.
Voltage-dependent effect of alpha-adrenoceptor antagonists on V max (Fig. 7) . The effect of 3 x 10- ..
... " . . The effect of yohimbine on the V max-membrane potential relation was also examined in two preparations in a similar manner (Fig. 7B ).
Discussion
Effect of alpha-adrenoceptor antagonists on the transient depolarization induced by low K+, high Ca2+ plus strophanthidin. The present study demonstrates that strophanthidininduced transient depolarization is suppressed by bunazosin, . . a new selective alpha 1 -adrenoceptor antagonist, and by yohimbine, which is reported to preferentially block alpha 2 -adrenoceptors. Previous studies (6, 7) on the effects of alphaadrenoceptor antagonists on ouabain-induced arrhythmia showed that selective alpha)-adrenoceptor blockade inhibited the arrhythmia whereas alpha 2 -adrenoceptor blockade increased it. These experiments were performed in anesthetized guinea pigs in which the adrenergic system was intact. In the present study, guinea pigs were pretreated with reserpine to lower the catecholamine content of the preparations, and ventricular papillary muscles perfused with Tyrode solution were used without any application of catecholamines. The discrepancies in the results with yohimbine may be attributable to these differences in preparation and condition. In nonreserpinized animals with intact adrenal glands, alpha2-adrenoceptor antagonism may increase the alpha 1 -adrenergic tone, and the arrhythmogenic effect of such alpha)-adrenoceptor stimulation might mask the antiarrhythmic effect of yohimbine. The present observations may be ascribed to the direct effect of drugs on muscle cells. Role in ventricular arrhythmias. The proposed mechanisms responsible for ventricular arrhythmias, especially during myocardial ischemia, are 1) reentrant excitation; 2) automaticity; and 3) some combination of these two mechanisms (35) . A recent study (36) to delineate the mechanisms for arrhythmias associated with reperfusion of ischemic HAS EGA W A ET AL. myocardium demonstrated that ventricular arrhythmia was most commonly initiated by a nonreentrant mechanism that might involve an abnormal form of automaticity or triggered activity. Kimura et a1. (5) described the tendency to triggered activity of cat Purkinje fibers after healing of myocardial infarction. Triggered activity induced by norepinephrine in hypoxic glucose-free conditions was recently demonstrated to be suppressed by yohimbine (9) . This finding is consistent with the depressant effect of yohimbine in the present study. The transient depolarization resulting in triggered activity is exaggerated by conditions that increase cellular Ca 2 + content, such as high Ca 2 +, low Na+ solution and low concentrations of caffeine (37) (38) (39) (40) . The transient depolarization reflects the transient inward current resulting from an oscillatory release of Ca2+ from the Ca 2 + -overloaded sarcoplasmic reticulum (41) . Because this current depends on the cellular Ca 2 + load to some extent (41, 42) , interventions to reduce the Ca 2 + load to the cells, such as applications of slow channel blocking agents, diminish it (41) . Furthermore, local anesthetic agents have been shown (43) to depress the strophanthidin-induced transient depolarization through a decreasing intracellular N a + and therefore intracellular Ca2+. The suppression not only of the Ca2+ current but also of the Na + current shown in the present study may explain the depressant effect on the transient depolarization induced by alpha-adrenoceptor antagonists.
ALPHA·ADRENERGIC BLOCKERS AS ANTIARRHYTHMICS
Effect of bunazosin on beta-adrenoceptor-mediated abnormal automaticity during hypoxia. Abnormal automaticity is another potential nonreentrant mechanism of arrhythmias.
Abnormal automatiCity occurs under specific conditions such as with the application of a depolarizing current pulse (44, 45) and exposure to catecholamine in Ba2+ -containing high K + solution (34, 46) , not only in Purkinje fibers, but also in ventricular muscle. The facilitatory effect of hypoxia on beta-adrenoceptor-and slow channel-mediated abnormal automaticity (33) was shown to be inhibited by application of bunazosin in our present study. Because no alphaadrenoceptor agonists were contained in the solution, this depressant effect of bunazosin on automaticity may result from the blocking effect of Ca2+ current, which plays a major role in the initiation of action potentials in high K + solutions (34, 47) .
The depressant effects of alpha-adrenoceptor antagonists on the slow Ca 2 + current were then tested ( Fig. 3 and 4) . Azuma et al. (15) found that at to 10-4 M, yohimbine enhanced the isoproterenol-induced slow action potentials in a few cases but lowered the mean values of V max and amplitude of slow action potentials. In the present study, yohimbine in low concentrations produced no augmentation of slow response but a significant decrease in V max and overshoot. These differences may be derived from the choice of method to induce the slow response in high K + or tetrodotoxin-containing solutions. The finding that bunazosin suppressed the slow response is compatible with the observation in voltage clamp experiments on the rabbit sinus node (14) .
These observations that not only an alpha]-adrenoceptor antagonist but also an alpha2-adrenoceptor antagonist and a nonselective alpha-adrenoceptor antagonist suppressed the slow channel of myocardial cells suggest that the slow channel blocking effect of alpha-adrenoceptor antagonists may contribute to their antiarrhythmic effect.
Use-dependeJlt and voltage-dependent effect of alphaadrenoceptor aqtagonists on V max of fast action potentials.
The fast Na + channel blocking effect (local anesthetic effect) of alpha-adrenoceptor antagonists was also elucidated in this study. Previous studies showed that V max of steady state action potentials of Purkinje fiber or ventricular muscle cell is suppressed by prazosin (11, 12) , phentolamine (10, 48) , yohimbine (12, 15, 16) and urapidil, a new alpha]-adrenoceptor antagonist (13) . In these studies, use dependency (10) and voltage dependency (48) of the phentolamine action were observed. In the present study the kinetics of usedependent block and voltage-dependent block of V max of action potentials for bunazosin and for yohimbine were examined. The characteristics of the use-dependent inhibition of V max induced by either bunazosin or yohimbine are similar to those of slow kinetic drugs such as disopyramide rather than to the characteristics of fast ones, according to the classification proposed by Courtney (26) .
Class I antiarrhythmic drugs have been classified into two or three subclasses from their use-dependent kinetics,
and their characteristics predicted based on their molecular JACC Vol. ]2, No. 6 December 1988 6 December : 1590 weight, pKa (the dissociation constant) and log P (the log of the n-octanol, water partition coefficient) (25) (26) (27) (28) (29) 49, 50) .
Analysis of V max inhibition based on the modulated receptor theory (17) and structural characteristics has been shown to be applicable (51) not only for antiarrhythmic drugs but also for other chemicals such as beta-adrenoceptor antagonists. The pKa for bunazosin is 7.7. Bunazosin (373.4) and yohimbine (354.4) have a much larger molecular weight than that of quinidine (324.4) or disopyramide (339) . The molecular size may be related to the slow recovery kinetics of these drugs. Previous studies (25-27 ,50,52) indicate that the rate of onset of use-dependent block is directly correlated with molecular weight, but not with lipid solubility, and increases with increasing drug concentration. The studies of recovery of V max from block (26, 49, 50) show a good direct correlation between molecular weight and recovery times of V max' Our present results are compatible with these observations. Clinical implications. Alpha-adrenoceptor antagonists have been reported to be effective in preventing cardiac arrhythmia in patients with myocardial infarction (2) . During myocardial ischemia, loss of K + from myocardium and extracellular K + accumulation occurs (53) . In th!(se conditions, membrane depolarization due to increased extracellular K + might exaggerate the voltage-dependent inhibition of Na + channel by alpha-adrenoceptor antagonists. Because alpha-adrenergic stimulation causes a restoration of the slow response (54) and increases the Ca 2 + load of the cell (55) (56) (57) , the increase of serum catecholamine concentration and the enhanced a,lpha-adrenergic responsiveness during myocardial ischemia (3) may facilitate the arrhythmogenicity induced by Ca 2 + overload of the myocardial cells. Indeed, the alpha-adrenoceptor antagonistic effect of drugs seems to prevent arrhythmias mainly in such conditions, but the suppression of fast Na + and slow Ca2+ currents induced by alpha-adrenoceptor antagonists might exert an additional role in their antiarrhythmic action.
Conclusions. This study demonstrates that alpha-adrenoceptor antagonists have an antiarrhythmic effect, especially in the arrhythmia induced by abnormal automaticity or triggered activity, probably through the inhibition of fast Na + and slow Ca + currents independently of blockade of cardiac alpha-adrenoceptors. The changes in V max and impulse conduction velocity produced by local anesthetics have been shown to correlate well and this relation has been recognized to be useful in applying the known effects of drugs on V max to impulse propagation (58) (59) (60) . Therefore, the depressant effect of alpha-adrenoceptor antagonists on the slow and fast action potentials demonstrated in the present study may suppress reentrant type arrhythmia.
